XPO1 and myelodysplastic syndrome: SF3B1 is the most commonly mutated spliceosomal gene in MDS and, although SF3B1 mutations are typically associated with good prognosis [53, 54], we saw a decrease in survival with increased XPO1 expression in SF3B1 mutations.